Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
CLVS | Clovis Oncology, Inc. | KLINGENSTEIN PAUL H | Director | Jul 29, 2019 | Option Exercise | $0.29 | 25,862 | 7,500 | 59,327 | Jul 31, 2019, 04:24 PM | |
CNAT | Conatus Pharmaceuticals Inc | KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Buy | $6.77 | 189,513 | 1,283,353 | 2,226,944 | Aug 01, 2013, 07:16 PM | |
CNAT | Conatus Pharmaceuticals Inc | KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Option Exercise | $6.77 | 4,462 | 30,227 | 52,419 | Aug 01, 2013, 07:16 PM | |
CLVS | Clovis Oncology, Inc. | KLINGENSTEIN PAUL H | Director | Nov 21, 2011 | Buy | $13.00 | 7,813 | 101,569 | 25,509 | Mar 22, 2012, 07:58 PM | |
CLVS | Clovis Oncology, Inc. | KLINGENSTEIN PAUL H | Director | Nov 21, 2011 | Buy | $13.00 | 391,478 | 5,089,214 | 1,278,156 | Mar 22, 2012, 07:58 PM | |
ANAC | Anacor Pharmaceuticals Inc | KLINGENSTEIN PAUL H | Director | Nov 30, 2010 | Buy | $5.00 | 300,000 | 1,500,000 | 1,751,936 | Dec 01, 2010, 06:05 PM |